Powder: -20°C for 3 years | In solvent: -80°C for 1 year
T-705RTP is a selective and GTP-competitive of influenza virus RNA polymerase(IC50 of 0.14 μM and a Ki of 1.52 μM), has potent anti-influenza virus activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry | |
100 mg | Inquiry | Inquiry |
Description | T-705RTP is a selective and GTP-competitive of influenza virus RNA polymerase(IC50 of 0.14 μM and a Ki of 1.52 μM), has potent anti-influenza virus activity. |
Targets&IC50 | Influenza virus RNA polymerase:(ki)1.52 μM , Influenza virus RNA polymerase:0.14 μM |
In vitro | T-705RTP sodium and T-705RMP are detected in MDCK cells treated with T-705. influenza virus RNA polymerase activity in a dose-dependent and a GTP-competitive manner inhibited by T-705RTP sodium[1]. T-705RTP inhibits the incorporation of ATP and GTP in a competitive manner (Ki of 7.72 and 1.56 μM, respectively). T-705RTP inhibits the incorporation of CTP in a mixed-type manner(Ki of 11.3 μM), and also inhibits the incorporation of UTP in a noncompetitive manner[2]. The incorporation of a single molecule of T-705RTP (10-1000 μM) inhibits influenza virus RNA strand extension[2]. |
Molecular Weight | 529.16 |
Formula | C10H15FN3O15P3 |
CAS No. | 740790-94-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
T-705RTP 740790-94-7 Others T705RTP T 705RTP inhibitor inhibit